Description: Aiforia Technologies Oyj, together with its subsidiary Aiforia Inc., equips pathologists and scientists in preclinical, clinical, and academic labs with deep learning artificial intelligence (AI) software for translating images into discoveries, decisions, and diagnoses in Finland, rest of Europe, North America, and internationally. The company offers AI-supported image-based diagnostic suites for breast cancer, lung cancer, and prostate cancer. It also provides Aiforia Create, which allows users to create and validate their own proprietary deep learning AI models, as well as train their AI models to identify, quantify, or measure features in any 2D image; and Aiforia Studies, a software module that offers AI-assisted image analysis workflow within the framework of good laboratory practices. In addition, the company offers integration, cloud hosting, and custom AI services. It serves pharmaceutical and biotechnology companies, contract research organizations, clinical laboratories, academic institutions, and other industries. Aiforia Technologies Oyj was incorporated in 2013 and is headquartered in Helsinki, Finland.
Home Page: www.aiforia.com
Pursimiehenkatu 29-31 D 610
Helsinki,
00150
Finland
Phone:
358 2073 49130
Officers
| Name | Title |
|---|---|
| Mr. Jukka Tapaninen M.Sc(Econ) | Chief Executive Officer |
| Dr. Johan Lundin M.D., Ph.D. | Co- Founder & Director |
| Mr. Veli-Matti Parkkonen | Chief Financial Officer |
| Ms. Kaisa Helminen | Chief Operating Officer |
| Mr. Panu Kauppila | Chief Product Officer & Member of the Management Board |
| Mr. Tuomas Ropponen | Chief Technology Officer |
| Mr. Manuel Ahlsten | Vice President of Marketing |
| Mr. Thomas Westerling-Bui Ph.D. | President of Americas |
| Mr. Tamas Regenyi | Chief Commercial Officer |
Exchange: HE
Country: FI : Finland
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Technology |
| GIC Sub-Industry: | Health Care Technology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 4.8061 |
| Price-to-Sales TTM: | 40.0825 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 78 |